Genomic Health, Inc. (GHDX): Hedge Funds Cashed Out Too Early
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Posts Tagged ‘(NASDAQ:GHDX)’
Hedge Funds Have Never Been This Bullish On Genomic Health, Inc. (GHDX)
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in...
Here’s What Hedge Funds Think About Genomic Health, Inc. (GHDX)
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Hedge Fund and Insider Trading News: Steve Cohen, Tom Steyer, Landec Corporation (LNDC), Genomic Health, Inc. (GHDX), and More
At a glance, you could argue that Florida has been a money pit for billionaire Tom Steyer’s political network.
Hedge Fund and Insider Trading News: Carl Icahn, Crispin Odey, ValueAct Capital, La Jolla Pharmaceutical (LJPC), New Mountain Finance Corp. (NMFC), and More
Billionaire activist investor Carl Icahn is building a stake in casino company Caesars Entertainment, sources familiar with the situation said.
Should You Buy Genomic Health, Inc. (GHDX)?
Insider Monkey finished processing more than 700 13F filings made by hedge funds and prominent investors.
13D Filing: Baker Bros. Advisors and Genomic Health Inc (GHDX)
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
13D Filing: Baker Bros. Advisors and Genomic Health Inc (GHDX)
You can access the original SEC filing by clicking here.
Is Genomic Health, Inc. (GHDX) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Hedge Funds Are Hoarding Shares of These 5 Small-Caps
Through extensive research we have determined that the best approach to outperform the broader indices is to follow hedge funds into their top small-cap ideas.
Is Genomic Health, Inc. (GHDX) A Good Stock To Buy?
With market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, low commodity prices and economic turmoil...
Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines Company (MDCO)
Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois.
Camber Capital Management Adds To Position In Genomic Health, Inc. (GHDX)
Stephen Dubois is optimistic about the prospects of Genomic Health, Inc. (NASDAQ:GHDX) and has increased his fund's holding of the stock.
Baker Bros. Advisors’ Latest Moves Involve Genomic Health, Inc. (GHDX), & Celsus Therapeutics PLC (ADR) (CLSXD)
Julian Baker and Felix Baker's Baker Bros. Advisors have disclosed in a new filing with the SEC adding approximately 4,100 shares to their stake in Genomic Health, Inc.
Should You Avoid Bio-Reference Laboratories Inc (BRLI)?
At the moment, there are dozens of gauges market participants can use to analyze the equity markets.
WuXi PharmaTech (Cayman) Inc. (ADR) (WX): Are Hedge Funds Right About This Stock?
In the eyes of many of your fellow readers, hedge funds are perceived as useless, old investment vehicles of an era lost to time.
What Hedge Funds Think About Genomic Health, Inc. (GHDX)
In the 21st century investor’s toolkit, there are plenty of indicators investors can use to monitor stocks. Some of the best are hedge fund and insider trading movement.
Genomic Health, Inc. (GHDX), Merck & Co., Inc. (MRK): Rest in Peace, Medicare?
Does Medicare have one foot in the grave already? The Trustees of the Medicare program recently announced that the program will remain solvent through 2026.
Hedge Funds Aren’t Crazy About WuXi PharmaTech (Cayman) Inc. (ADR) (WX) Anymore
Is WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) ready to rally soon? Prominent investors are taking a pessimistic view.
Hedge Funds Aren’t Crazy About Genomic Health, Inc. (GHDX) Anymore
Is Genomic Health, Inc. (NASDAQ:GHDX) a sound investment today? Investors who are in the know are reducing their bets on the stock.
Apple Inc. (AAPL), QUALCOMM, Inc. (QCOM): Disruptions Needed
Take the $2.8 trillion spent last year in the U.S. on health care and add another 70% to the total.
Pharmacyclics, Inc. (PCYC), Genomic Health, Inc. (GHDX)…Mega-Hedge Fund Focusing on The Life Sciences
The $3+ billion Baker Brothers Advisors equity portfolio, managed by brothers Julian and Felix Baker, focuses almost exclusively on life science companies with a small to medium...
Genomic Health, Inc. (GHDX): Insiders Are Buying, Should You?: ICON plc – Ordinary Shares (ICLR), Novadaq Technologies Inc. (NVDQ)
Is Genomic Health, Inc. (NASDAQ:GHDX) an attractive investment today? Prominent investors are becoming hopeful.
